Sorry, your browser doesn't support embedded videos.

5 days ago · About Encoded Therapeutics Encoded Therapeutics is a clinical-stage biotechnology company developing precision genetic medicines to transform the lives of patients with severe …

6 days ago · Delivered as a single intracerebroventricular injection, the therapy is designed to provide long-term benefit and potentially address the full range of DS symptoms. ETX101, an investigational …

Dec 5, 2025 · Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech on track to start a pivotal study next year. The Californian...

Jan 8, 2026 · Encoded Therapeutics Highlights Progress in Dravet Syndrome Program and Pipeline Ahead of Company Presentation at 44th Annual J.P. Morgan Healthcare Conference – Positive …

Sep 2, 2025 · Encoded Therapeutics is a clinical-stage genetic medicines company developing potentially one-time, disease-modifying therapies for severe neurological disorders.

Feb 19, 2025 · Encoded Therapeutics is a clinical-stage biotechnology company developing AAV-based gene therapies for severe CNS disorders. Its proprietary platform combines novel AAV vector …

5 days ago · Encoded Therapeutics, Inc. (“Encoded”), a clinical-stage biotechnology company developing precision genetic medicines for severe neurological disorders, today announced that the …

Encoded Therapeutics is creating one-time, disease-modifying gene therapies for pediatric central nervous system (CNS) disorders with its cell-selective targeting and regulation platform.

Our team brings to Encoded the right mix of innovation and expertise across all aspects of gene therapy development. Watch our lab tour. From whiteboard to lab and from lab to clinic, our team knows how …